Danish biotech Teitur Trophics says its experimental Parkinson’s treatment TT-P34 has successfully completed Phase 1 trials, showing both safety and early signs that it can reach the brain and central nervous system. The company now plans to move into Phase 2 trials in 2027, supported by ...
BioLife has secured a major US patent that could shape how weight-loss and diabetes medicines are taken in the future, especially GLP-1 drugs that are currently mostly given by injection. Here is a simple breakdown of what was announced and why it matters. What BioLife has ...
As popular as peptide therapies have become in oncology and metabolic research, a new industry report suggests their next frontier may be in conjugate platforms. According to SNS Insider, the global peptide drug conjugates (PDC) market is projected to grow from USD 3.85 billion in 2025 ...
As popular as the peptide GLP‑1 boom has been worldwide, completely revolutionizing weight loss for millions, a common criticism is that this kind of treatment remains reserved for the upper class. Under that notion, Brazil is wrestling with whether its public healthcare system (SUS) should provide ...
For the first time in more than a decade, the U.S. adult obesity rate is experiencing a statistically meaningful decline. After peaking at 39.9% in 2022, the national rate has gradually fallen to 36.4% in 2026, according to Gallup’s National Health and Well‑Being Index. Public health ...
MBX Biosciences has named Jeff Held, J.D., as its new Chief Legal Officer, bringing more than three decades of legal and compliance leadership to the precision peptide therapy company. The firm is one of the few clinical‑stage biotechs explicitly focused on precision peptide therapies for endocrine ...
A new social media-driven trend is pushing some teenagers to use unregulated peptide injections in pursuit of improved appearance, muscle growth, and skin changes. Promoted through “looksmaxxing” communities on TikTok and Instagram, these compounds are being ordered online and used at home, often without medical supervision. ...
A growing online trend called “sperm-maxxing” is spreading across social media, where men attempt to improve fertility through supplements, hormones, peptides, diet changes, and extreme biohacking methods. But medical experts say much of the advice circulating online is misleading, oversimplified, or not supported by strong clinical ...
The next generation of peptide-based products could become a massive global market. Still, experts say the financial rewards are likely to be widely distributed rather than dominated by a few pharmaceutical giants. Peptides, short chains of amino acids used in treatments ranging from weight loss to ...
Peptides, once limited to hospitals and research labs, are now widely promoted online as “miracle” solutions for weight loss, skin health, muscle recovery and even anti-aging. But medical experts say the rapid rise of these products is happening far faster than the science behind them. Today, ...
Structure Therapeutics has announced encouraging clinical trial results across two of its lead programs in chronic weight management: ACCG‑2671, an oral small molecule amylin receptor agonist, and aleniglipron, an oral GLP‑1 receptor agonist. The company says the findings strengthen its position in the race to deliver ...
A recent report from Biotech Insider argues that while replacing insulin‑producing beta cells has shown promise in Type 1 diabetes patients, the central challenge remains keeping those cells alive in the face of immune rejection. The commentary notes that trials have already demonstrated patients coming off ...
